Literature DB >> 24251164

Visual disturbances as a presenting feature of pseudohypoparathyroidism.

Rushikesh Maheshwari1, Radha P Rani, Rajendra N Prasad, Karthik T S Reddy, Amaresh P Reddy.   

Abstract

INTRODUCTION: Visual disturbance as a presenting feature of pseudohypoparathyroidism (PHP) is uncommon. Although papilledema is commonly reported with hypoparathyroidism primary or secondary, but not reported commonly with PHP. DESCRIPTION OF THE CASE: A 10-year-old male child presented to our outpatient service with the complaints of blurring of vision, diplopia, and associated headache. There was no history of seizure episode. Patient had rounded face with a short, stocky built. Shortening of the fourth metacarpal and fifth metatarsal was present. Pitted nails and bilateral cataract. Patient also had clinical signs and biochemical parameters of hypocalcemia, along with normal parathyroid hormone (PTH) levels. Consistent with pseudohypopathyroidism.
CONCLUSION: In cases of chronic papilledema, the assessment of the calcium serum level is a safe and simple method to exclude hypoparathyroidism or PHP.

Entities:  

Keywords:  AHO Phenotype; Pseudohypoparathyroidism; papilledema

Year:  2013        PMID: 24251164      PMCID: PMC3830310          DOI: 10.4103/2230-8210.119577

Source DB:  PubMed          Journal:  Indian J Endocrinol Metab        ISSN: 2230-9500


INTRODUCTION

Pseudohypoparathyroidism (PHP) is an inherited metabolic disorder characterized by end organ resistance to the action of parathyroid hormone (PTH). PTH maintains serum calcium levels by promoting bone resorption, enhanced distal tubular reabsorption of calcium, and increased synthesis of 1,25-dihydroxyvitamin D, thereby causing enhanced intestinal calcium absorption. Resistance to PTH, therefore leads to hypocalcemia and hyperphophatemia.[1] Chronic hypocalcemia is responsible for increase in intracranial tension, thus causing papilledema, hence visual disturbances.[2]

DESCRIPTION OF THE CASE

A 10-year-old male child presented to our outpatient service with the complaints of blurring of vision, double vision, and dimness of vision. History of headache was present. Patient also had history of cramping pain of extremities with spasms more in lower limb and calf muscles. On clinical examination patient had rounded face with a short, stocky built. There was brachydactyly. Shortening of the fourth metacarpal and fifth metatarsal was present. Pitted nails and broad thumb. Bilateral cataract was present and fundus was showing presence of papilledema [Figure 1]. Trousseau's sign was positive suggestive of hypocalcemia. Findings were consistent with pseudohypopathyroidism with Albright's hereditary osteodystrophy (AHO) phenotype.[3]
Figure 1

Fundus photograph of the patient before and after treatment

Fundus photograph of the patient before and after treatment Biochemical analysis is shown in Table 1. In presence of clinical features and biochemical analysis showing hypocalcemia, [Table 1] serum parathyroid levels were measured. Serum PTH value was 38.6 pg/ml which was normal. Urinary calcium was 3.57 mg/dl and urinary creatinine was 3.77 mg/dl, thus indicating renal tubular calcium loss.
Table 1

Serum biochemistry of the patient

Serum biochemistry of the patient In presence of hypocalcemia, renal tubular calcium loss and normal PTH and AHO phenotype, patient was labeled as a case of PHP. Features of raised intracranial tension were resolved once patient was started on treatment with oral calcium, phosphate binders along with active vitamin D3.

DISCUSSION

PHP is called “pseudo” hypoparathyroidism because the blood chemistry values (low to normal serum calcium and high serum phosphorous) resemble the more common disorder hypoparathyroidism in which PTH is absent or low, but PTH is actually normal or elevated because the kidney cannot fully respond to PTH.[4] A multifactorial etiology for bilateral disc edema can be postulated, such as impaired axoplasmic conduction due to reduced calcium and stasis, impaired central nervous system (CNS) vascular autoregulation causing venous stasis, and raised intracranial pressure due to pseudotumor cerebri.[2] The papilledema in hypocalcemia does not behave like that due to intracranial space occupying lesion or cerebral venous thrombosis. The disc edema readily responds to calcium therapy and disappears with calcium levels higher than 8 mg/dl.[5] Our patient also improved with normal fundoscopic findings [Figure 1] and clinical and biochemical [Table 1] improvement.

CONCLUSION

In cases of chronic papilledema, the assessment of the calcium serum level is a safe and simple method to exclude hypoparathyroidism or PHP.
  3 in total

1.  Discordance between genetic and epigenetic defects in pseudohypoparathyroidism type 1b revealed by inconsistent loss of maternal imprinting at GNAS1.

Authors:  Suzanne Jan de Beur; Changlin Ding; Emily Germain-Lee; Justin Cho; Alexander Maret; Michael A Levine
Journal:  Am J Hum Genet       Date:  2003-07-11       Impact factor: 11.025

2.  Convulsions and papilledema in a child with idiopathic hypoparathyroidism.

Authors:  W M FOWLER; S LING
Journal:  Calif Med       Date:  1961-09

3.  Albright's hereditary osteodystrophy (pseudohypoparathyroidism type Ia): clinical case with a novel mutation of GNAS1.

Authors:  Livia Garavelli; S Pedori; C Zanacca; G Caselli; A Loiodice; G Mantovani; A Ammenti; Raffaele Virdis; G Banchini
Journal:  Acta Biomed       Date:  2005-04
  3 in total
  3 in total

1.  Hypoparathyroidism Should Always Be Checked in Papilledema.

Authors:  Peter Gradisnik
Journal:  J Neurosci Rural Pract       Date:  2017 Jul-Sep

Review 2.  Recommendations for Diagnosis and Treatment of Pseudohypoparathyroidism and Related Disorders: An Updated Practical Tool for Physicians and Patients.

Authors:  Giovanna Mantovani; Murat Bastepe; David Monk; Luisa de Sanctis; Susanne Thiele; S Faisal Ahmed; Roberto Bufo; Timothée Choplin; Gianpaolo De Filippo; Guillemette Devernois; Thomas Eggermann; Francesca M Elli; Aurora Garcia Ramirez; Emily L Germain-Lee; Lionel Groussin; Neveen A T Hamdy; Patrick Hanna; Olaf Hiort; Harald Jüppner; Peter Kamenický; Nina Knight; Elvire Le Norcy; Beatriz Lecumberri; Michael A Levine; Outi Mäkitie; Regina Martin; Gabriel Ángel Martos-Moreno; Manasori Minagawa; Philip Murray; Arrate Pereda; Robert Pignolo; Lars Rejnmark; Rebeca Rodado; Anya Rothenbuhler; Vrinda Saraff; Ashley H Shoemaker; Eileen M Shore; Caroline Silve; Serap Turan; Philip Woods; M Carola Zillikens; Guiomar Perez de Nanclares; Agnès Linglart
Journal:  Horm Res Paediatr       Date:  2020-08-05       Impact factor: 2.852

Review 3.  Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement.

Authors:  Giovanna Mantovani; Murat Bastepe; David Monk; Luisa de Sanctis; Susanne Thiele; Alessia Usardi; S Faisal Ahmed; Roberto Bufo; Timothée Choplin; Gianpaolo De Filippo; Guillemette Devernois; Thomas Eggermann; Francesca M Elli; Kathleen Freson; Aurora García Ramirez; Emily L Germain-Lee; Lionel Groussin; Neveen Hamdy; Patrick Hanna; Olaf Hiort; Harald Jüppner; Peter Kamenický; Nina Knight; Marie-Laure Kottler; Elvire Le Norcy; Beatriz Lecumberri; Michael A Levine; Outi Mäkitie; Regina Martin; Gabriel Ángel Martos-Moreno; Masanori Minagawa; Philip Murray; Arrate Pereda; Robert Pignolo; Lars Rejnmark; Rebecca Rodado; Anya Rothenbuhler; Vrinda Saraff; Ashley H Shoemaker; Eileen M Shore; Caroline Silve; Serap Turan; Philip Woods; M Carola Zillikens; Guiomar Perez de Nanclares; Agnès Linglart
Journal:  Nat Rev Endocrinol       Date:  2018-08       Impact factor: 43.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.